Summary of Study ST004341
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002753. The data can be accessed directly via it's Project DOI: 10.21228/M8SZ7B This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST004341 |
| Study Title | Effects of honey on alcohol-associated liver disease (ALD): Honey combined with ethanol modeling and serum metabolomics |
| Study Summary | Background: Honey, unlike some other common sweeteners, contains diversity of unique biologically active compounds with potential hepato-protective properties. This study aimed to investigate the effects of honey on alcohol-associated liver disease (ALD) and to compare it with a mixture of sugars (39% fructose, 28% glucose, and 4% sucrose). Methods: This study modeled ALD in C57BL/6J mice by feeding them a liquid diet containing 5% ethanol. Concurrently, mice received oral interventions with honey (4 g/kg body weight) and mixed sugars (4 g/kg body weight). At the conclusion of the 18-day experiment, serum, organs, and intestinal contents were collected for analysis. Results: Honey reduced hepatic steatosis, decreased inflammatory gene expression and improved antioxidant capacity compared to mice on a diet mixed with sugar. Meanwhile, honey reduced serum long-chain fatty acid levels and increased short-chain fatty acid (SCFA) levels in cecal contents. In addition, non-targeted metabolomics results indicated that honey ameliorates alcoholic liver injury by modulating steroid hormone biosynthesis and 2 alpha-linolenic acid metabolism. Furthermore, gut flora analyses revealed that honey increased beneficial bacteria such as GCA-900066575 (which produces butyric acid), Dubosiella spp. (which produces propionic acid) and Mucispirillum spp. (which protects the gut barrier). These beneficial bacteria increased SCFA levels in the gut, improved intestinal damage and reduced systemic inflammation. Conclusions: This study demonstrates the potential health benefits of honey in the management of ALD. The mechanisms include remodelling the gut microbiota, promoting metabolic homeostasis and reducing inflammation. The findings o this study provide foundation for the use of honey as a potential dietary intervention in management of metabolic diseases such as ALD. |
| Institute | Chinese Academy of Agricultural Sciences Institute of Apiculture Research |
| Last Name | Zheng |
| First Name | |
| Address | Xiangshan, Haidian, Beijing, BEIJING, 100081, China |
| zhengxing@caas.cn | |
| Phone | +86 15600523029 |
| Submit Date | 2025-11-01 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | mzML |
| Analysis Type Detail | LC-MS |
| Release Date | 2025-11-15 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
| Project ID: | PR002753 |
| Project DOI: | doi: 10.21228/M8SZ7B |
| Project Title: | Honey combined with ethanol modeling and serum metabolomics |
| Project Summary: | Honey, unlike some other common sweeteners, contains diversity of unique biologically active compounds with potential hepato-protective properties. This study aimed to investigate the effects of honey on alcohol-associated liver disease (ALD) and to compare it with a mixture of sugars (39% fructose, 28% glucose, and 4% sucrose). |
| Institute: | Chinese Academy of Agricultural Sciences Institute of Apiculture Research |
| Last Name: | Zheng |
| First Name: | |
| Address: | Xiangshan, Haidian, Beijing, BEIJING, 100081, China |
| Email: | zhengxing@caas.cn |
| Phone: | +86 15600523029 |
Subject:
| Subject ID: | SU004500 |
| Subject Type: | Mammal |
| Subject Species: | Mus musculus |
| Taxonomy ID: | 10090 |
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
| mb_sample_id | local_sample_id | Sample source | treatment |
|---|---|---|---|
| SA509388 | POS_Ethanol group-6 | Mouse blood | Ethanol |
| SA509389 | NEG-QC3 | Mouse blood | Ethanol |
| SA509390 | NEG-QC4 | Mouse blood | Ethanol |
| SA509391 | NEG-QC5 | Mouse blood | Ethanol |
| SA509392 | NEG-QC6 | Mouse blood | Ethanol |
| SA509393 | NEG_Ethanol group-2 | Mouse blood | Ethanol |
| SA509394 | POS_Ethanol group-2 | Mouse blood | Ethanol |
| SA509395 | POS_Ethanol group-3 | Mouse blood | Ethanol |
| SA509396 | POS_Ethanol group-4 | Mouse blood | Ethanol |
| SA509397 | POS_Ethanol group-5 | Mouse blood | Ethanol |
| SA509398 | POS_Ethanol group-7 | Mouse blood | Ethanol |
| SA509399 | NEG-QC1 | Mouse blood | Ethanol |
| SA509400 | POS_Ethanol group-8 | Mouse blood | Ethanol |
| SA509401 | POS_Ethanol group-9 | Mouse blood | Ethanol |
| SA509402 | POS_Ethanol group-10 | Mouse blood | Ethanol |
| SA509403 | POS-QC1 | Mouse blood | Ethanol |
| SA509404 | POS-QC2 | Mouse blood | Ethanol |
| SA509405 | POS-QC3 | Mouse blood | Ethanol |
| SA509406 | POS-QC4 | Mouse blood | Ethanol |
| SA509407 | POS-QC5 | Mouse blood | Ethanol |
| SA509408 | POS-QC6 | Mouse blood | Ethanol |
| SA509409 | NEG-QC2 | Mouse blood | Ethanol |
| SA509410 | NEG_Ethanol group-1 | Mouse blood | Ethanol |
| SA509411 | POS_Ethanol group-1 | Mouse blood | Ethanol |
| SA509412 | NEG_Ethanol group-7 | Mouse blood | Ethanol |
| SA509413 | NEG_Ethanol group-10 | Mouse blood | Ethanol |
| SA509414 | NEG_Ethanol group-8 | Mouse blood | Ethanol |
| SA509415 | NEG_Ethanol group-9 | Mouse blood | Ethanol |
| SA509416 | NEG_Ethanol group-6 | Mouse blood | Ethanol |
| SA509417 | NEG_Ethanol group-5 | Mouse blood | Ethanol |
| SA509418 | NEG_Ethanol group-4 | Mouse blood | Ethanol |
| SA509419 | NEG_Ethanol group-3 | Mouse blood | Ethanol |
| SA509420 | POS_Ethanol+Honey group-10 | Mouse blood | Ethanol+Honey |
| SA509421 | POS_Ethanol+Honey group-8 | Mouse blood | Ethanol+Honey |
| SA509422 | POS_Ethanol+Honey group-7 | Mouse blood | Ethanol+Honey |
| SA509423 | POS_Ethanol+Honey group-6 | Mouse blood | Ethanol+Honey |
| SA509424 | POS_Ethanol+Honey group-5 | Mouse blood | Ethanol+Honey |
| SA509425 | POS_Ethanol+Honey group-4 | Mouse blood | Ethanol+Honey |
| SA509426 | POS_Ethanol+Honey group-2 | Mouse blood | Ethanol+Honey |
| SA509427 | POS_Ethanol+Honey group-1 | Mouse blood | Ethanol+Honey |
| SA509428 | POS_Ethanol+Honey group-9 | Mouse blood | Ethanol+Honey |
| SA509429 | POS_Ethanol+Honey group-3 | Mouse blood | Ethanol+Honey |
| SA509430 | NEG_Ethanol+Honey group-1 | Mouse blood | Ethanol+Honey |
| SA509431 | NEG_Ethanol+Honey group-7 | Mouse blood | Ethanol+Honey |
| SA509432 | NEG_Ethanol+Honey group-2 | Mouse blood | Ethanol+Honey |
| SA509433 | NEG_Ethanol+Honey group-10 | Mouse blood | Ethanol+Honey |
| SA509434 | NEG_Ethanol+Honey group-8 | Mouse blood | Ethanol+Honey |
| SA509435 | NEG_Ethanol+Honey group-9 | Mouse blood | Ethanol+Honey |
| SA509436 | NEG_Ethanol+Honey group-6 | Mouse blood | Ethanol+Honey |
| SA509437 | NEG_Ethanol+Honey group-5 | Mouse blood | Ethanol+Honey |
| SA509438 | NEG_Ethanol+Honey group-4 | Mouse blood | Ethanol+Honey |
| SA509439 | NEG_Ethanol+Honey group-3 | Mouse blood | Ethanol+Honey |
| SA509440 | NEG_Ethanol+Sugar group-7 | Mouse blood | Ethanol+Sugar |
| SA509441 | POS_Ethanol+Sugar group-8 | Mouse blood | Ethanol+Sugar |
| SA509442 | NEG_Ethanol+Sugar group-8 | Mouse blood | Ethanol+Sugar |
| SA509443 | NEG_Ethanol+Sugar group-9 | Mouse blood | Ethanol+Sugar |
| SA509444 | NEG_Ethanol+Sugar group-10 | Mouse blood | Ethanol+Sugar |
| SA509445 | NEG_Ethanol+Sugar group-4 | Mouse blood | Ethanol+Sugar |
| SA509446 | NEG_Ethanol+Sugar group-3 | Mouse blood | Ethanol+Sugar |
| SA509447 | POS_Ethanol+Sugar group-10 | Mouse blood | Ethanol+Sugar |
| SA509448 | POS_Ethanol+Sugar group-9 | Mouse blood | Ethanol+Sugar |
| SA509449 | POS_Ethanol+Sugar group-3 | Mouse blood | Ethanol+Sugar |
| SA509450 | POS_Ethanol+Sugar group-7 | Mouse blood | Ethanol+Sugar |
| SA509451 | POS_Ethanol+Sugar group-6 | Mouse blood | Ethanol+Sugar |
| SA509452 | POS_Ethanol+Sugar group-5 | Mouse blood | Ethanol+Sugar |
| SA509453 | POS_Ethanol+Sugar group-4 | Mouse blood | Ethanol+Sugar |
| SA509454 | POS_Ethanol+Sugar group-2 | Mouse blood | Ethanol+Sugar |
| SA509455 | POS_Ethanol+Sugar group-1 | Mouse blood | Ethanol+Sugar |
| SA509456 | NEG_Ethanol+Sugar group-2 | Mouse blood | Ethanol+Sugar |
| SA509457 | NEG_Ethanol+Sugar group-1 | Mouse blood | Ethanol+Sugar |
| SA509458 | NEG_Ethanol+Sugar group-6 | Mouse blood | Ethanol+Sugar |
| SA509459 | NEG_Ethanol+Sugar group-5 | Mouse blood | Ethanol+Sugar |
| Showing results 1 to 72 of 72 |
Collection:
| Collection ID: | CO004493 |
| Collection Summary: | After the mice inhale carbon dioxide, blood is collected via the orbital sinus, and serum is obtained after centrifugation. |
| Sample Type: | Blood (serum) |
Treatment:
| Treatment ID: | TR004509 |
| Treatment Summary: | Thirty mice were randomly divided into three groups (n=10/group): (1) Ethanol group (gavage of purified water), (2) Ethanol+Honey group (gavage of 4 g honey /kg body weight), (3) Ethanol+Sugar group (gavage of 4 g mixed sugar/kg body weight). |
Sample Preparation:
| Sampleprep ID: | SP004506 |
| Sampleprep Summary: | In brief, serum samples (100 uL) were extracted with 400 uL of methanol and acetonitrile (1:1, v/v), and the extraction efficiency was facilitated by vortexing and sonication. The samples were centrifuged, and the supernatant was dried. The serum was then re-solubilized with methanol and acetonitrile (1:1, v/v). Finally, the supernatant extract was filtered (0.22 um nylon membrane) before metabolite analysis. The instrumentation was based on an Agilent HPLC system combined with quadrupole time-of-flight mass spectrometry (HPLC-Q-TOF/MS, 6545, Agilent Technologies, Palo Alto, CA, USA). The test method was also adopted in our previous study. |
Chromatography:
| Chromatography ID: | CH005502 |
| Instrument Name: | Agilent 1290 |
| Column Name: | Agilent Zorbax Eclipse Plus C18 (100 x 2.1mm, 1.8 um) |
| Column Temperature: | 30 °C |
| Flow Gradient: | 0 min/5% B, 2 min/5% B, 20min/100% B, 25 min/100% B |
| Flow Rate: | 0.3 mL/min |
| Solvent A: | 100% water; 0.1% formic acid |
| Solvent B: | 100% acetonitrile; 0.1% formic acid |
| Chromatography Type: | Reversed phase |
Analysis:
| Analysis ID: | AN007249 |
| Analysis Type: | MS |
| Chromatography ID: | CH005502 |
| Num Factors: | 3 |
| Num Metabolites: | 2840 |
| Has Mz: | 1 |
| Has Rt: | 1 |
| Rt Units: | Minutes |
| Results File: | ST004341_AN007249_Results.txt |
| Units: | Peak area |
| Analysis ID: | AN007250 |
| Analysis Type: | MS |
| Chromatography ID: | CH005502 |
| Num Factors: | 3 |
| Num Metabolites: | 922 |
| Has Mz: | 1 |
| Has Rt: | 1 |
| Rt Units: | Minutes |
| Results File: | ST004341_AN007250_Results.txt |
| Units: | Peak area |